A detailed history of F Dx Advisors, Inc. transactions in Natera, Inc. stock. As of the latest transaction made, F Dx Advisors, Inc. holds 3,707 shares of NTRA stock, worth $633,155. This represents 0.13% of its overall portfolio holdings.

Number of Shares
3,707
Previous 4,655 20.37%
Holding current value
$633,155
Previous $504,000 6.55%
% of portfolio
0.13%
Previous 0.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$97.75 - $129.67 $92,667 - $122,927
-948 Reduced 20.37%
3,707 $471,000
Q2 2024

Aug 02, 2024

SELL
$85.28 - $112.6 $38,717 - $51,120
-454 Reduced 8.89%
4,655 $504,000
Q1 2024

May 03, 2024

BUY
$59.21 - $92.9 $44,229 - $69,396
747 Added 17.13%
5,109 $467,000
Q4 2023

Feb 12, 2024

BUY
$37.55 - $62.64 $163,793 - $273,235
4,362 New
4,362 $273,000
Q2 2023

Jul 17, 2023

BUY
$47.08 - $55.16 $623,904 - $730,980
13,252 New
13,252 $644,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.6B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track F Dx Advisors, Inc. Portfolio

Follow F Dx Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.